Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial to Evaluate the Safety and Feasibility of CK0801 in Treatment of Bone Marrow Failure Syndrome

NCT03773393 is registered in ClinicalTrials.gov with Cellenkos, Inc. as lead sponsor.

NCT NCT03773393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03773393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial to Evaluate the Safety and Feasibility of CK0801 in Treatment of Bone Marrow Failure Syndrome
Lead sponsor
Cellenkos, Inc.
Phase
Phase 1
Overall status
Active, not recruiting
Start date
May 30, 2019
Completion date
May 30, 2027
Enrollment
18 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bone marrow disease